Comparison between Renol Polychem IPO and Spinaroo Commercial IPO.
Renol Polychem IPO is a SME Fixed Price IPO proposed to list at NSE SME while Spinaroo Commercial IPO is a SME Fixed Price proposed to list at BSE SME.
| Renol Polychem IPO | Spinaroo Commercial IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Corporate Makers Capital Ltd. | Finshore Management Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Black Fox Financial Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Renol Polychem IPO is up to ₹24.20 Cr whereas the issue size of the Spinaroo Commercial IPO is up to ₹9.66 Cr. The final issue price of Renol Polychem IPO is ₹105.00 per share and of Spinaroo Commercial IPO is ₹51.00 per share.
| Renol Polychem IPO | Spinaroo Commercial IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹100.00 per share | |
| Issue Price (Upper) | ₹105.00 per share | |
| Issue Price (Final) | ₹105.00 per share | ₹51.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 23,05,200 shares | 18,94,000 shares |
| Fresh Issue Size (Amount) | up to ₹24.20 Cr | up to ₹9.66 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 23,05,200 shares | 18,94,000 shares |
| Issue Size Total (Amount) | up to ₹24.20 Cr | up to ₹9.66 Cr |
Renol Polychem IPO opens on Jul 31, 2025, while Spinaroo Commercial IPO opens on Mar 28, 2025. The closing date of Renol Polychem IPO and Spinaroo Commercial IPO is Aug 04, 2025, and Apr 03, 2025, respectively.
| Renol Polychem IPO | Spinaroo Commercial IPO | |
|---|---|---|
| Anchor Bid Date | Jul 30, 2025 | |
| Issue Open | Jul 31, 2025 | Mar 28, 2025 |
| Issue Close | Aug 04, 2025 | Apr 03, 2025 |
| Basis Of Allotment (Tentative) | Aug 05, 2025 | Apr 04, 2025 |
| Initiation of Refunds (Tentative) | Aug 06, 2025 | Apr 07, 2025 |
| Credit of Share (Tentative) | Aug 06, 2025 | Apr 07, 2025 |
| Listing date (Tentative) | Aug 07, 2025 | Apr 08, 2025 |
| Anchor Lockin End date 1 | Sep 04, 2025 | |
| Anchor Lockin End date 2 | Nov 03, 2025 |
Renol Polychem IPO P/E ratio is 11.54, as compared to Spinaroo Commercial IPO P/E ratio of 18.21.
| Renol Polychem IPO | Spinaroo Commercial IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Renol Polychem Ltd. Financial Information (Restated)Renol Polychem Ltd.'s revenue increased by 859% and profit after tax (PAT) rose by 226% between the financial year ending with March 31, 2025 and March 31, 2024.
| Spinaroo Commercial Limited Financial Information (Restated Standalone)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 66.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.11 | 47.66 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.54 | 18.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹83.41 Cr. | ₹35.67 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 45.37% | 23.23% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 64.18% | 37.58% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.52 | 1.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.10 | ₹2.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 45.37% | 23.23% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Renol Polychem IPO Retail Individual Investors (RII) are offered 13,15,200 shares while in Spinaroo Commercial IPO retail investors are offered 13,15,200 shares. Qualified Institutional Buyers (QIB) are offered 2,56,800 shares in Renol Polychem IPO and 0 shares in Spinaroo Commercial IPO.
| Renol Polychem IPO | Spinaroo Commercial IPO | |
|---|---|---|
| Anchor Investor Reserveration | 3,84,000 shares | 0 shares |
| Market Maker Reserveration | 1,48,800 shares | 1,00,000 shares |
| QIB | 2,56,800 shares | 0 shares |
| NII | 3,49,200 shares | 9,46,000 shares |
| RII | 13,15,200 shares | 9,48,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 23,05,200 shares | 18,94,000 shares |
Renol Polychem IPO subscribed 6.83x in total, whereas Spinaroo Commercial IPO subscribed 1.52x.
| Renol Polychem IPO | Spinaroo Commercial IPO | |
|---|---|---|
| QIB (times) | 8.41x | |
| NII (times) | 6.89x | 1.84x |
| Big NII (times) | 7.21x | |
| Small NII (times) | 6.25x | |
| RII (times) | 6.51x | 1.20x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 6.83x | 1.52x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
